VLDL lipidomics reveals hepatocellular lipidome changes in metabolic dysfunction–associated steatotic liver disease
David Guardamino Ojeda(Beth Israel Deaconess Medical Center), Z. Gordon Jiang(Beth Israel Deaconess Medical Center), John M. Asara(Beth Israel Deaconess Medical Center), Susmita Bhattarai(Beth Israel Deaconess Medical Center), Melissa Miller(Northeastern University), Yered Pita-Juárez(Broad Institute), Yusuf Yalcin(Beth Israel Deaconess Medical Center), Zsu‐Zsu Chen(Beth Israel Deaconess Medical Center), Margery A. Connelly(Brigham and Women's Hospital), Aaron Hakim(Brigham and Women's Hospital), Michelle Lai(Beth Israel Deaconess Medical Center)
Cited by 4
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
|Nature Genetics|2011|1.1k